Delivery Order SPE2DB20D3103-SPE2DB22FM9E1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,308.80 Firm Fixed Price delivery order contract is for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has an Ultimate Completion Date of August 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,617.47 firm fixed-price delivery order is for the supply of OCELLA 3 MG-0.03 MG tablets, a medical product used in healthcare. The award has an ultimate completion date of October 18, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award for $2,364.92 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen). The delivery order is for the pharmaceutical product OCELLA 3 MG-0.03 MG TABLET 28S, a prescription...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,109.58 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Ocella 3 mg-0.03 mg tablet, 28 count, with a completion date of March 7, 2023. This award is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $1,098.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ocella 3 mg-0.03 mg tablets (28-count packaging) on August 12, 2025, with ultimate completion by August 13, 2025. This is a non-set-aside competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's medical supply...
- This contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,954.42, is for the delivery of the pharmaceutical product OCELLA 3-0.3MG 84S. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2024. This contract is not associated with a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for OCELLA 3-0.3MG 84S (a birth control medication) valued at $2,418.80 on October 15, 2025, with completion scheduled for October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.36 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $913 to Amerisourcebergen Drug Corporation to supply 4561573850 OCELLA 3 MG-0.03 MG tablets. As the prime contractor, Amerisourcebergen will deliver 28 count packages of the oral contraceptive medication to a location in Conshohocken, Pennsylvania by July 24, 2023 in support of DLA procurement programs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $497.55 delivery order by the Defense Logistics Agency Troop Support Medical to provide 4561971082 OCELLA 3 MG-0.03 MG TABLETS in 28 count packages. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order is for a one day period of August 28 through August 29, 2023. No subcontractors or set aside designations were identified. The...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM9E1Delivery Order
This federal contract award, valued at $1,314.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ocella 3 mg-0.03 mg tablets in quantities of 28 per package. The award represents a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/7/22 |